Program Description
Transitions of care (TOC) is defined as the movement from one setting of care to another. It is estimated that 60% of all medication errors occur during TOC. Novel approaches have been pursued and implemented among various organizations in an effort to improve various stages of TOC. Pharmacists are critical members of the health care team that can prevent and reduce medication errors in order to optimize and advance TOC-related outcomes. This webinar activity explores the medication use-related risks during various phases of the TOC continuum and will compare selected examples of TOC continuous quality improvement projects
Target audience: Pharmacists
Type of activity: Application
Release date: September 29, 2022
Expiration date: November 29, 2022
Time to complete activity: 1.0 hour
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
- Identify medication-use related risks across the transitions of care continuum
- Contrast selected continuous improvement approaches as solutions to improving transitions of care

Michael C. Dejos, PharmD, MBA, BCPS, CHOP, LSSBB, DPLA
System Medication Safety Officer
Department of Patient Safety and Quality
Methodist Le Bonheur Healthcare
Assistant Professor
Department of Clinical Pharmacy and Translational Science
College of Pharmacy, Memphis Campus
The University of Tennessee Health Science Center
Memphis, Tennessee

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hour (0.10 CEU) under the ACPE universal activity number 0290-0000-22-382-L05-P. The activity is available for CE credit through November 29, 2022.
Instructions for Completing the Activity and Receiving CPE Credit
To receive CPE credit, participants must complete the pretest, review the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.
Disclosures
Michael C. Dejos, PharmD, MBA, BCPS, CHOP, LSSBB, DPLA, has the following financial relationships with commercial interests to disclose:
Stock/Shareholder: Johnson & Johnson, Becton Dickinson, Amerisource Bergen Company, Pfizer
Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Karleen Melody, PharmD; Abigail Dill; Susan Pordon; Brianna Winters; and Chloe Taccetta have no relevant financial relationships with commercial interests to disclose.
An anonymous peer reviewer was used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.
Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.
For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms


